Inventor · disambiguated record
Shinji Morimoto
Also filed as: MORIMOTO SHINJI
13 granted patents·5 pending applications·90 citations·filing 1998–2023
91Inventor score
Top patents by PatentIndex Score
18 records- 0193US9718814B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Aug 1, 2017·5 cites·2 claims
- 0293US9714241B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 25, 2017·5 cites·2 claims
- 0393US9487511B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Nov 8, 2016·5 cites·2 claims
- 0489US10807987B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 20, 2020·5 cites·8 claims
- 0589US10053456B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 21, 2018·3 cites·7 claims
- 0688US9751885B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Sep 5, 2017·15 cites·10 claims
- 0788US9527807B2Sulfonamide derivative and use thereofFUKUMOTO SHOJI·Filed 2012·Granted Dec 27, 2016·26 cites·11 claims
- 0886US2024317733A1Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0984US11702419B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jul 18, 2023·1 cites·18 claims
- 1078US11407748B2Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor functionTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 9, 2022·1 cites·12 claims
- 1176US6407116B1Nitrogenous fused-ring compounds, process for the preparation of the same, and drugsTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1998·Granted Jun 18, 2002·24 cites·10 claims
- 1275US10968213B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Apr 6, 2021·0 cites·1 claims
- 1375US2021179603A1Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1470US10414761B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 17, 2019·0 cites·1 claims
- 1566US9920047B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Mar 20, 2018·0 cites·1 claims
- 1650US2023348435A11-((1h-pyrazol-4-yl)methyl)-3-(phenyl)-1,3-dihydro-2h-imidazol-2-one derivatives and related compounds as gpr139 antagonists for the treatment of e.g. depressionTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1746US2008275085A1Piperidine derivative and use thereofSHIRAI JUNYA·Filed 2008·Application pending·0 cites
- 1843US2022089525A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shinji Morimoto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →